Active Preoperative Anemia Management to Reduce Erythrocyte Transfusion in Patients Undergoing Cardiac Surgery (APART): A Pilot, Feasibility Study
Phase of Trial: Phase I/II
Latest Information Update: 27 Sep 2019
Price : $35 *
At a glance
- Drugs Ferumoxytol (Primary) ; Erythropoietin
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms APART
- 24 Sep 2019 Status changed from recruiting to discontinued.
- 31 Aug 2018 Biomarkers information updated
- 07 Feb 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2020.